Literature DB >> 31291017

Neuromodulation for the Acute and Preventive Therapy of Migraine and Cluster Headache.

Rashmi B Halker Singh1, Jessica Ailani2, Matthew S Robbins3.   

Abstract

Headache disorders are among the most common and disabling medical conditions worldwide. Pharmacologic acute and preventive treatments are often insufficient and poorly tolerated, and the majority of patients are unable to adhere to their migraine treatments due to these issues. With improvements in our understanding of migraine and cluster headache pathophysiology, neuromodulation devices have been developed as safe and effective acute and preventive treatment options. In this review, we focus on neuromodulation devices that have been studied for migraine and cluster headache, with special attention to those that have gained food and drug administration (FDA) clearance. We will also explore how these devices can be used in patients who might have limited pharmacologic options, including the elderly, children, and pregnant women.
© 2019 American Headache Society.

Entities:  

Keywords:  cluster headache; migraine acute treatment; migraine prevention; neuromodulation; neurostimulation

Year:  2019        PMID: 31291017     DOI: 10.1111/head.13586

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  Noninvasive Neuromodulation in Migraine.

Authors:  Benzion Blech; Amaal J Starling
Journal:  Curr Pain Headache Rep       Date:  2020-12-16

Review 2.  Outcomes of transcutaneous nerve stimulation for migraine headaches: a systematic review and meta-analysis.

Authors:  Adam G Evans; Abigail N Horrar; Maryo M Ibrahim; Brady L Burns; Christopher L Kalmar; Patrick E Assi; Krista N Brooks-Horrar; Tigran Kesayan; Salam Al Kassis
Journal:  J Neurol       Date:  2022-03-16       Impact factor: 6.682

3.  Percutaneous Bioelectric Current Stimulation for Chronic Cluster Headache - A Possible Transformative Approach to Cluster Headache.

Authors:  Albrecht Molsberger; Colin D McCaig
Journal:  J Pain Res       Date:  2020-04-23       Impact factor: 3.133

4.  MRI Evaluation of the Relationship Between Abnormalities in Vision-Related Brain Networks and Quality of Life in Patients with Migraine without Aura.

Authors:  Wenqiang Cui; Jiwei Zhang; Fei Xu; Hongwei Zhi; Haitao Li; Baopeng Li; Sishuo Zhang; Wei Peng; Hongyun Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-08       Impact factor: 2.570

5.  A Resting-State Functional Magnetic Resonance Imaging Study of Abnormal Frontoparietal Network Function in Migraine without Aura.

Authors:  Wen-Qiang Cui; Si-Shuo Zhang; Fei Xu; Hai-Tao Li; Hong-Wei Zhi; Ya-Han Wang; Yong-Jun Huo; Xiang-Qing Xu; Hong-Yun Wu
Journal:  Med Sci Monit       Date:  2022-01-21

6.  Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.

Authors:  Christina L Szperka; Jessica Ailani; Rebecca Barmherzig; Brad C Klein; Mia T Minen; Rashmi B Halker Singh; Robert E Shapiro
Journal:  Headache       Date:  2020-04-03       Impact factor: 5.311

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.